§ 13-7A-01. Definitions
West's Annotated Code of MarylandHealth--GeneralEffective: October 1, 2020
Effective: October 1, 2020
MD Code, Health - General, § 13-7A-01
§ 13-7A-01. Definitions
(b) “Agent” means an individual who:
(c) “Anaphylaxis” means a sudden, severe, and potentially life-threatening allergic reaction that occurs when an individual is exposed to an allergen.
(d) “Auto-injectable epinephrine” means a portable, disposable drug delivery device that contains a premeasured single dose of epinephrine that is used to treat anaphylaxis in an emergency situation.
(e) “Certificate” means a certificate issued by the Department to an individual to obtain, store, and administer auto-injectable epinephrine.
(f) “Certificate holder” means an individual who is authorized by the Department to obtain, store, and administer auto-injectable epinephrine to be used in an emergency situation.
(g) “Eligible institution” means an institution of higher education that has a food service facility or a recreation and wellness facility on the premises and that is authorized under this subtitle to obtain and store auto-injectable epinephrine.
(h) “Food service facility” has the meaning indicated in § 21-301 of this article.
(i) “Participating facility” means a recreation or wellness facility at an eligible institution or a food service facility, including a food service facility at an eligible institution, in the State that voluntarily participates in the Program.
Credits
Added by Acts 2018, c. 527, § 1, eff. Oct. 1, 2018. Amended by Acts 2020, c. 478, § 1, eff. Oct. 1, 2020; Acts 2020, c. 479, § 1, eff. Oct. 1, 2020.
MD Code, Health - General, § 13-7A-01, MD HEALTH GEN § 13-7A-01
Current with legislation effective through July 1, 2023, from the 2023 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document |